A drug for autoimmune disease Sjögren's syndrome, picked up by Novartis when it bought MorphoSys for $2.9 billion last year, has hit the target in a pair of phase 3 trials. Ianalumab (VAY736), a drug ...
If my makeup routine has five steps, one of them is always lip gloss. If it’s pared down to three steps, it's still a non-negotiable. And if I had to choose just one must-have product? You guessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results